DRREDDY

Dr. Reddy's Laboratories Limited

Source: NSE · Updated 4 Nov, 06:28 pm IST

Filed 23 Oct, 06:49 pm IST Q2 FY27 (Sep ’26)Consolidated₹ millions

Revenue

86,978

▼ 1.5% vs Q2 FY26

Operating profit (EBITDA, derived from filing)

17,306

▼ 13.9% vs Q2 FY26

Net profit

9,132

▼ 31.7% vs Q2 FY26

EPS (₹)

11.10

▼ 31.4% vs Q2 FY26

Operating margin

19.9%

−290 bps vs Q2 FY26

Net margin

10.5%

−460 bps vs Q2 FY26

Revenue down, profit down vs Q2 FY26

Revenue−1% vs Q2 FY26 · +7% vs Q1 FY27

Profit−32% vs Q2 FY26 · +110% vs Q1 FY27

View official filing ↗

Numbers from the company's structured XBRL filing on NSE, cross-checked with P&L totals.

Previous-quarter and year-ago figures: as originally reported in those quarters' NSE filings; filing PDF not available to confirm restatements.

Quarter comparison

Item	Q2 FY27 (Sep ’26)	Q1 FY27 (Jun ’26)	vs Q1 FY27	Q2 FY26 (Sep ’25)	vs Q2 FY26
Revenue from operations	86,978	80,998	▲ 7.4%	88,283	▼ 1.5%
Other income	1,562	3,547	▼ 56.0%	3,239	▼ 51.8%
Total income	88,540	84,545	▲ 4.7%	91,522	▼ 3.3%
Total expenses	76,187	79,020	▼ 3.6%	74,137	▲ 2.8%
Operating profit (EBITDA)*	17,306	8,599	▲ 101.3%	20,099	▼ 13.9%
Profit before tax	12,353	5,525	▲ 123.6%	17,385	▼ 28.9%
Tax expense	3,144	1,177	▲ 167.1%	4,080	▼ 22.9%
Net profit	9,132	4,356	▲ 109.6%	13,368	▼ 31.7%
EPS (₹)	11.10	5.33	▲ 108.3%	16.18	▼ 31.4%
Operating margin	19.9%	10.6%	+930 bps	22.8%	−290 bps
Net margin	10.5%	5.4%	+510 bps	15.1%	−460 bps

Showing Q2 FY27 (Sep ’26) and change vs Q2 FY26. Turn your phone sideways for Q1 FY27 (Jun ’26).

Figures in ₹ millions except EPS. Consolidated figures from the company's XBRL filing on NSE. Each row is shown only if it reconciles with the others (e.g. PBT − tax = net profit); rows we couldn't verify are left out. Net margin = net profit ÷ revenue. *Operating profit (EBITDA), derived from the filing: profit before exceptional items and tax + finance costs + depreciation − other income. Operating margin = EBITDA ÷ revenue.

All Dr. Reddy's Laboratories results, dividends & filings ›

Other results filed 23 Oct

UNIECOM Unicommerce Esolutions Limited›SETCO Setco Automotive Limited›PANACHE Panache Digilife Limited›SPLPETRO Supreme Petrochem Limited›REPRO Repro India Limited›MAHLOG Mahindra Logistics Limited›COFORGE Coforge Limited›KSOLVES Ksolves India Limited›OFSS Oracle Financial Services Software Limited›TRIVENIPT Triveni Power Transmission Limited›UTIAMC UTI Asset Management Company Limited›CSBBANK CSB Bank Limited›

Today's results ›

DR. REDDY'S LABORATORIES Q2 FY27 ; NET PROFIT DOWN 32% AT ₹913 CR (YOY), UP 110% (QOQ)

REVENUE DOWN 1% AT ₹8,698 CR (YOY), UP 7% (QOQ)

EBITDA DOWN 14% AT ₹1,731 CR (YOY), UP 101% (QOQ)

MARGINS AT 19.9% VS 22.8% (YOY), 10.6% (QOQ)

https://resultkal.com/r/drreddy-2026-10-23
Source: NSE filing · not investment advice

FAQ

When did Dr. Reddy's Laboratories announce Q2 FY27 results?

Dr. Reddy's Laboratories filed its results on NSE on 23 Oct, 06:49 pm IST.

What does QoQ and YoY mean?

QoQ compares with the previous quarter; YoY compares with the same quarter last year. Growth is calculated from the figures in the filing.

Are these Dr. Reddy's Laboratories figures official?

They are auto-read from the company's NSE filing and may contain errors. Always confirm with the official PDF linked on this page.

Explore

Today's results Results this week Q2 FY27 results dates Dividend stocks this week Bonus issue 2026 Stock split 2026

Figures are auto-read from the company's NSE filing and may contain errors. Check the official filing before deciding. Not investment advice.

← DRREDDY overview